Lonza continues realization of long-term strategic initiatives
10-May-2006
This manufacturing initiative was designed to support increased production capacity for rheumatoid arthritis indicated ORENCIA® (abatacept), which will enable Bristol-Myers Squibb to meet the anticipated long-term demand.
Most read news
Organizations
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.